Delivery Order SPE2DB22D7065-SPE2DB24FH2JJ

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S." The contract has a ceiling value of $3,097.72 and a period of performance through July 19, 2024. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen, through its Corporate Office division, is responsible for delivering the requested eye drops to support federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $6,377.97. The contract is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" and has a firm fixed price pricing type. The ultimate completion date is May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of REFRESH PLUS 0.5% EYE DROPS 30S. The contract has a ceiling value of $2,717.51 and a completion date of July 22, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has extensive experience in providing pharmaceutical and medical products to various federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S". The award, valued at $2,023.45, is a firm fixed-price contract that runs through August 8, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical commodities to various government agencies, including the DLA, through its extensive federal...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of "REFRESH PLUS 0.5% EYE DROPS UD 70S" medical supplies. The contract has a firm fixed price of $3,302.55 and is a delivery order under the larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC allows the agency to efficiently procure a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of "REFRESH PLUS 0.5% EYE DROPS UD 50S", a medical commodity used in healthcare settings. The contract has a ceiling value of $1,700.05 and was awarded on December 5, 2024, with a completion date of December 6, 2024. The contract is a firm fixed price delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S". The contract has a ceiling value of $2,205.07 and an ultimate completion date of December 20, 2024. It is a firm-fixed-price contract, which indicates a predetermined price for the goods or services provided. The contract does not have a set-aside designation, suggesting it was awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $2,719.69 firm fixed price contract is for the delivery of 4564483232 REFRESH PLUS 0.5% EYE DROPS 30S and has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S" medical supplies, with a ceiling value of $1,921.45 and a completion date of January 27, 2025. The contract is a firm fixed-price delivery order type, with no set-aside designation. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,745.72 firm fixed-price delivery order is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" medical products. The contract has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D7065
    Indefinite Delivery Contract
  • SPE2DB22D7065-SPE2DB24FH2JJ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S". The award, with a ceiling value of $1,272.12, is under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order has a firm fixed price pricing type and an ultimate completion date of August 5, 2024. The contract does not have a set-aside designation.

Generated 11/1/24, 9:03 AM